Navigation Links
Global Cervical Artificial Disc Market to Hit $1 Billion by 2012
Date:3/18/2008

Global cervical artificial disc market will see a compound annual growth rate of 65% from 2008 through 2012, according to Millennium Research Group

WALTHAM, Mass., March 18 /PRNewswire/ -- According to Millennium Research Group's (MRG) Global Markets for Spinal Nonfusion Technologies 2008 report, which covers markets in the US, Europe, and Asia Pacific regions, the global cervical artificial disc market will grow from a value of just under $60 million in 2007 to approximately $1 billion in 2012.

Several factors will be integral in facilitating growth in this market, including increased adoption of Synthes Spine's and Medtronic Spinal and Biologics' cervical artificial discs in the US, the release of newly designed products from numerous different competitors, a familiar surgical approach to that of anterior cervical fusion, as well as an increased use of multiple discs in a single procedure.

"Both patients and surgeons alike are excited about cervical artificial disc technology," says Kevin Flewwelling, Manager of MRG's Orthopedics division. "Patients benefit from the increased motion preservation associated with cervical artificial discs, as well as the shorter recovery times, which enables them to return quickly to their regular lifestyles. Surgeons, on the other hand, are comfortable with the surgical technique and are attracted by the technologies' ability to restore physiological motion and minimize adjacent-level disc disease."

The Global Markets for Spinal Nonfusion Technologies 2008 report covers the artificial disc, dynamic stabilization, nuclear disc replacement, annulus repair, and facet arthroplasty markets. Industry competitors include Abbott Spine, Aesculap Implant Systems, Anulex Technologies, Biomet Spine, Cervitech, DePuy Spine, LDR Spine, Medtronic Spinal and Biologics/Kyphon, NuVasive, Paradigm Spine, Raymedica, Scient'x, SpineVision, Stryker Spine, Synthes Spine, Trans1, and Zimmer Spine.

About Cervical Artificial Discs

With age, intervertebral discs may begin to dehydrate and lose their ability to retain water, contributing to severe pain and decreased mobility. Artificial discs were developed to treat chronic back pain while allowing for the preservation of physiological vertebral motion through proper intervertebral spacing and stability.

About Millennium Research Group

Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc. company (http://www.DecisionResources.com), is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Amy Krohn

Millennium Research Group

416-364-7776 x101

akrohn@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Winners Announced in HopeLabs Global Competition to Get Kids Moving!
2. West Pharmaceutical Services to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
3. Robotic Surgeons From Around the World Attend One-of-a-Kind Conference by Global Robotics Institute at Florida Hospital
4. Exelixis Announces March 19 Webcast of Presentation at the Lehman Brothers Annual Global Healthcare Conference
5. Murad, Inc., Hires Lori Jacobus as Vice President of Global Marketing
6. Brookdale to Present at Lehman Global Healthcare Conference on March 19
7. HealthSouth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference and the 2008 Credit Suisse Global Leveraged Finance Conference
8. Accordia Global Health Foundation Convenes Inaugural Infectious Diseases Summit
9. First Lady Laura Bush Joins Susan G. Komen for the Cure (R) to Launch Global Promise Fund Assisting Women Worldwide
10. Previously Disclosed Changes in Board Composition of NightHawk Radiology Holdings, Inc. Prompt Notice of Noncompliance from the Nasdaq Global Market
11. Biomarkers and Innovation Push Global Cancer Diagnostics Market Toward $8 Billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of ... Farma Brasil as the company,s second affiliate in Latin America . ... ... Manager of Astellas Farma Colombia ... ...
Breaking Medicine Technology: